Search

everythinglearnresearchcommunity

for

Search:↓

PRIDE syndrome includes skin and hair issues from cancer treatment with EGFR inhibitors.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Progesterone may help trans women with breast development and health, but more research is needed.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Nephronectin is linked to worse breast cancer outcomes and helps cancer spread.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

Some gonadal hormone drugs can block filovirus entry into cells.

Erlotinib may cause scarring hair loss.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

EGFR inhibitors can cause skin issues, and managing these is important for treatment success.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Oral contraceptives and antiandrogens are effective for treating hirsutism, with antiandrogens being the most effective.

Targeting EGFR may help reduce hair loss from chemotherapy.

Aptamers can improve wound healing and promote hair growth.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Rapunzel syndrome can show vague symptoms and needs long-term psychiatric care to prevent recurrence.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Cyproterone acetate can effectively treat idiopathic hirsutism, but ethinyl oestradiol and lynoestrenol may not always reduce hair growth.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Women also use 5α-reductase inhibitors for hair loss and hirsutism.